{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:45:38Z","timestamp":1792158338440,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,19]],"date-time":"2014-01-19T00:00:00Z","timestamp":1390089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00059-013-4038-1","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T12:57:45Z","timestamp":1389963465000},"page":"528-533","source":"Crossref","is-referenced-by-count":14,"title":["Role of anticardiolipin antibodies in the pathogenesis of prosthetic valve thrombosis","Rolle der Anticardiolipin-Antik\u00f6rper in der Pathogenese der Thrombose von Herzklappenprothesen"],"prefix":"10.1007","volume":"40","author":[{"given":"A.\u00c7.","family":"Aykan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"G\u00f6kdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kal\u00e7\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Astarc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Karakoyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.O.","family":"G\u00fcrsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"O\u011fuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ert\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"\u00c7akal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,19]]},"reference":[{"key":"4038_CR1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309\u20131311","journal-title":"Arthritis Rheum"},{"key":"4038_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"4038_CR3","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","volume":"87","author":"McNeil","year":"1990","unstructured":"McNeil HP, Simpson RJ, Chesterman CN et al (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120\u20134124","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4038_CR4","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","volume":"335","author":"Galli","year":"1990","unstructured":"Galli M, Comfurius P, Maassen C et al (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544\u20131547","journal-title":"Lancet"},{"key":"4038_CR5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcmg.2012.10.016","volume":"6","author":"Ozkan","year":"2013","unstructured":"Ozkan M, G\u00fcnd\u00fcz S, Biteker M et al (2013) Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. JACC Cardiovasc Imaging 6:206\u2013216","journal-title":"JACC Cardiovasc Imaging"},{"key":"4038_CR6","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0735-1097(00)00654-9","volume":"35","author":"\u00d6zkan","year":"2000","unstructured":"\u00d6zkan M, Kaymaz C, K\u0131rma C et al (2000) Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. J Am Coll Cardiol 35:1881\u20131889","journal-title":"J Am Coll Cardiol"},{"key":"4038_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1616089","volume":"86","author":"Tincani","year":"2001","unstructured":"Tincani A, Allegri F, Sanmarco M et al (2001) Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations: a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 86:575\u2013583","journal-title":"Thromb Haemost"},{"key":"4038_CR8","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0038-1649988","volume":"74","author":"Brandt","year":"1995","unstructured":"Brandt JT, Barna LK, Triplett DA (1995) Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. Thromb Haemost 74:1597\u20131603","journal-title":"Thromb Haemost"},{"key":"4038_CR9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1160\/TH04-12-0839","volume":"93","author":"Pengo","year":"2005","unstructured":"Pengo V, Biasiolo A, Pegoraro C et al (2005) Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 93:1147\u20131152","journal-title":"Thromb Haemost"},{"key":"4038_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0961203306074767","volume":"16","author":"Tarr","year":"2007","unstructured":"Tarr T, Lakos G, Bhattoa HP et al (2007) Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus 16:39\u201345","journal-title":"Lupus"},{"key":"4038_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1160\/TH06-05-0287","volume":"96","author":"Ruffatti","year":"2006","unstructured":"Ruffatti A, Tonello M, Del Ross T et al (2006) Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 96:337\u2013341","journal-title":"Thromb Haemost"},{"key":"4038_CR12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.291.5.576","volume":"291","author":"The","year":"2004","unstructured":"The APASS Writing Committee (2004) Antiphospholipid antibodies and subsequent thrombo-occlusiveevents in patients with ischemic stroke. JAMA 291:576\u2013584","journal-title":"JAMA"},{"key":"4038_CR13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","volume":"104","author":"Schulman","year":"1998","unstructured":"Schulman S, Svenungsson E, Granqvist S (1998) Duration of anticoagulation study group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 104:332\u2013338","journal-title":"Am J Med"},{"key":"4038_CR14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2005.01485.x","volume":"3","author":"Groot","year":"2005","unstructured":"Groot PG de, Lutters B, Derksen RH et al (2005) Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost 3:1993\u20131997","journal-title":"J Thromb Haemost"},{"key":"4038_CR15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/berh.2002.0259","volume":"16","author":"Petri","year":"2002","unstructured":"Petri M (2002) Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 16:847\u2013858","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4038_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1445-5994.1990.tb01025.x","volume":"20","author":"Shi","year":"1990","unstructured":"Shi W, Krilis SA, Chong BH et al (1990) Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 20:231\u2013236","journal-title":"Aust N Z J Med"},{"key":"4038_CR17","first-page":"3","volume":"115","author":"Crowther","year":"2005","unstructured":"Crowther MA, Wisloff F (2005) Evidence based treatment of the antiphospholipid syndrome II: optimal anticoagulant therapy for thrombosis. Thromb Res 115:3\u20138","journal-title":"Thromb Res"},{"key":"4038_CR18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","volume":"340","author":"Kearon","year":"1999","unstructured":"Kearon C, Gent M, Hirsh J et al (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 340:901\u2013907","journal-title":"N Engl J Med"},{"key":"4038_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","volume":"349","author":"Kearon","year":"2003","unstructured":"Kearon C, Ginsberg JS, Kovacs MJ et al (2003) Comparison of low-intensity warfarin therapy with conventional- intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349:631\u2013639","journal-title":"N Engl J Med"},{"key":"4038_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","volume":"117","author":"Rosove","year":"1992","unstructured":"Rosove MH, Brewer PM (1992) Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117:303\u2013308","journal-title":"Ann Intern Med"},{"key":"4038_CR21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","volume":"332","author":"Khamashta","year":"1995","unstructured":"Khamashta MA, Cuadrado MJ, Mujic F et al (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993\u2013997","journal-title":"N Engl J Med"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-4038-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-013-4038-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-4038-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:06:41Z","timestamp":1565118401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-013-4038-1"}},"subtitle":["An observational study","Eine Beobachtungsstudie"],"short-title":[],"issued":{"date-parts":[[2014,1,19]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1007\/s00059-013-4038-1","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,19]]}}}